Clinical Trial Update: Phase 1 Safety Study of Dimethyl Sulfoxide Cryopreserved Platelets [Phase 1]

View source ↗

Summary

Phase 1 safety study of dimethyl sulfoxide cryopreserved platelets has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombocytopenia

Drugs mentioned

• Dimethyl Sulfoxide cryopreserved platelets (dimethyl sulfoxide cryopreserved platelets)

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Thrombocytopenia | Phase 1 | Status: COMPLETED | Results posted: 2021-05-20